Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

December 15, 2023

https://www.globenewswire.com/news-release/2023/07/20/2708024/0/en/Eliem-Therapeutics-Announces-Plans-to-Explore-Strategic-Alternatives.html

SEATTLE and CAMBRIDGE, United Kingdom, July 20, 2023 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq:ELYM) today announced that it has completed a review of its business, including the status of its programs, resources, and capabilities, and has made the determination to halt further development of its Kv7 program and to conduct a comprehensive exploration of strategic alternatives focused on maximizing shareholder value. Eliem has engaged Leerink Partners to act as a strategic advisor in the process.

Read more at globenewswire.com

Related news for (ELYM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.